Gentherm shareholders approved key proposals at a Special Meeting held on September 10, 2026, clearing the final corporate governance hurdles for its Reverse Morris Trust combination with Modine Manufacturing Company’s Performance Technologies business. Approximately 94.8% of outstanding shares voted in favor, with 99% of votes cast supporting the share issuance proposal and 94% supporting the charter amendment to increase authorized common stock. The transaction is expected to close on October 1, 2026, subject to customary closing conditions. Gentherm operates in the automotive and medical sectors, providing thermal management and pneumatic comfort technologies.

Gentherm reported second quarter 2026 product revenues of $416.2 million, an 11.0% increase year-over-year. Net income rose to $4.4 million from $0.5 million in the prior year, while adjusted diluted earnings per share reached $0.75 compared to $0.54. The company raised its full-year 2026 guidance, forecasting product revenues between $1.55 billion and $1.65 billion and adjusted EBITDA between $185 million and $200 million. Additionally, the Board terminated its $150 million 2024 stock repurchase program and authorized a new $400 million program effective July 27, 2026, spanning three years. Gentherm also completed key deliverables for its planned combination with Modine Performance Technologies and acquired Innovative Medical Equipment, LLC. Gentherm is a thermal management and pneumatic comfort technology provider for automotive and medical markets.

Gentherm Incorporated entered into a Third Amended and Restated Credit Agreement on June 29, 2026, providing a $550 million secured five-year revolving credit facility with Bank of America, N.A. as administrative agent. The facility includes a $50 million sublimit for swing line loans and a $30 million sublimit for letters of credit. Gentherm operates in the automotive and medical technology industries, providing thermal management solutions.